Haloperidol versus second ‐generation antipsychotics in the long‐term treatment of schizophrenia

ConclusionsPatients treated with atypical antipsychotics appear to continue pharmacotherapy longer than patients treated with haloperidol. In addition, atypical antipsychotics seem to be more protective against recurrences than haloperidol. However, these results should be cautiously interpreted in the light of potential confounder factors such as duration of illness. Copyright © 2016 John Wiley & Sons, Ltd.

Source: Human Psychopharmacology: Clinical and Experimental - June 12, 2016 Category: Psychiatry Authors: Massimiliano Buoli, Ren é S. Kahn, Marta Serati, A. Carlo Altamura, Wiepke Cahn Tags: Research Article Source Type: research